3M Drug Delivery Systems opened its new laboratory site at the 3M Singapore facility. The laboratory will develop products in both the Inhalation and Transdermal categories, complementing 3M Drug Delivery Systems’ well established global laboratory network, which has sites in St. Paul, Minnesota, USA and Loughborough, UK.

“This new site will help us provide Asia-Pacific customers with a product development service that has both local and global capabilities,” said Jim Vaughan, Vice President and General Manager, 3M Drug Delivery Systems Division.  “Singapore’s excellent infrastructure and highly qualified workforce make it an ideal fit for 3M’s needs.”

 “The new 3M Drug Delivery Systems Lab in Singapore also has the capacity and know-how to take unique formulations developed in the Asian region along the development path: from feasibility, development, manufacturing quality assurance as well as global regulatory expertise. This site will also play a vital role in the development of 3M’s innovative technologies, which can benefit patients worldwide,” added Vaughan.

Donald Chang, Managing Director, Singapore and Southeast Asia Region elaborated: “Our new team in Singapore will deliver product development service that balances local regulatory understanding and regional responsiveness with the high quality support of a global laboratory network that is second to none.”

Currently, products developed by the Singapore laboratory will be suitable for manufacture in 3M’s worldwide network of manufacturing sites, or the customers’ own facilities, and will be developed in line with global standards.  The 20,000sq ft facility is configured in a scalable design to enable it to expand when customer demand grows.